Improved Physicochemical Stability and Retinoblastoma Anticancer Activity of Salt-Caged Acid–Base Neutralized Melphalan Loaded in L-Glutathione and pH Responsive Fattigated Nanoparticles
Bo Gyeong Yang, Hai Van Ngo, Son Nhu Nguyen, Nam Hoai Dinh, Beom-Jin Lee · 2026
Read Improved Physicochemical Stability and Retinoblastoma Anticancer Activity of Salt-Caged Acid–Base Neutralized Melphalan Loaded in L-Glutathione and pH Responsive Fattigated Nanoparticles by Bo Gyeong Yang, Hai Van Ngo, Son Nhu Nguyen, Nam Hoai Dinh, Beom-Jin Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13622936.txt.
Description
Yang and colleagues developed in 2026 a nanoparticle formulation meant to make the eye cancer drug melphalan safer and longer lasting. Melphalan breaks down quickly in water and reaches the eye poorly, and injections are invasive. Their approach first neutralizes the drug into stable salt-caged aggregates. It then loads the drug into fatty nanoparticles built from hyaluronic acid that respond to acidity and glutathione.
The loaded particles stayed stable, passed barriers better than free drug, and released the drug in a controlled way. They killed retinoblastoma cells more effectively while sparing normal cells. The team offers the design as a route to gentler eye chemotherapy.
Catalog record
| CREATOR | Bo Gyeong Yang, Hai Van Ngo, Son Nhu Nguyen, Nam Hoai Dinh, Beom-Jin Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |